He had been seen in the Emergency Department on [**2112-4-17**] for a cough and shortness of breath and was treated with levofloxacin for presumed pneumonia and a prednisone taper for presumed chronic obstructive pulmonary disease flare.
In the Emergency Department on [**2112-4-20**], the patient was given Atrovent nebulizers, oxygen, intravenous Solu-Medrol and levofloxacin and a chest x-ray was performed.
During his treatment, he was unable to keep his mask on and he was given a 100% nonrebreather mask.
He was then put on BiPAP at 50% oxygen but continued to have labored respirations.
He was intubated and taken to the Medical Intensive Care Unit.
The patient was weaned off the ventilator within 36 hours after his admission to the Medical Intensive Care Unit.
He was treated with intravenous Solu-Medrol, which was later changed to p.o.
prednisone, and with levofloxacin for pneumonia and a chronic obstructive pulmonary disease flare as well as a likely hypercarbic respiratory arrest on his admission to the Emergency Department.
MEDICATIONS ON ADMISSION TO MEDICINE FLOOR: Levofloxacin 500 mg p.o.
Enteric coated aspirin 325 mg p.o.
Heparin 5,000 units subcutaneous b.i.d.
Prilosec 20 mg p.o.
Insulin sliding scale associated with fingersticks q.i.d.
Atrovent nebulizers every four hours.
Norvasc 5 mg p.o.
Prednisone 60 mg p.o.
Tylenol 650 mg p.o.
Ocean saline spray at two sprays per nostril p.r.n.
He was sitting in a chair with nasal cannula in place, watching television and in no apparent distress.
Total calculated carbon dioxide was 35.
Pneumonia:  During his hospital stay on the Medicine floor, the patient continued to receive levofloxacin 500 mg p.o.
as well as oxygen via nasal cannula to keep his oxygen saturation greater than 92%.
Chronic obstructive pulmonary disease:  While on the floor, the patient continued to receive Atrovent nebulizers every four hours as well as Flonase and Ocean spray p.r.n.
He also continued to receive prednisone 60 mg p.o.
During his stay on the Medicine floor, he continued to receive enteric coated aspirin 325 mg p.o.
and Norvasc 5 mg p.o.
with the application of an insulin sliding scale.
His diabetes was controlled at home through diet and did not require insulin or other medications.
During his stay on the floor, the patient received Prilosec 20 mg p.o.
PROPHYLAXIS:  During his stay on the Medicine floor, the patient received subcutaneous heparin 5,000 units b.i.d., which was discontinued once he began ambulating.
He also had pneumoboots in bed until he also began ambulating.
DISCHARGE MEDICATIONS: Levofloxacin 500 mg p.o.
Enteric coated aspirin 325 mg p.o.
Prilosec 20 mg p.o.
Norvasc 7.5 mg p.o.
Tylenol 650 mg p.o.
Prednisone taper as follows:  60 mg p.o.
